The COO of RCBC holds a working meeting with the CEO of Beijing Peace Tour Cultural Exchange Center and the deputy General Director of Stroytransgaz JSC

The COO of the Russian-Chinese Business Council Evgeny Markin held a working meeting with the CEO of Beijing (China) Peace Tour Cultural Exchange Shao Changchun and the deputy General Director of Stroytransgaz JSC Aleksander Kulish.

The participants discussed the possibility of joint implementation of investment projects in the field of medical facilities and management.

In addition, they discussed cooperation related to creating joint ventures for the production of medical devices and pharmaceuticals. 

Today, the Chinese medical and pharmaceutical market is one of the largest in the world, so we shall focus on the cooperation of Russian entities introducing production innovations with key Chinese partners. Extended business relationship between Russian and Chinese experts contributes to successful clinical trials and creation of new drugs in China and Russia and is the basis for medical business partnership.

During the meeting, the participants paid special attention to creating joint multi-purpose medical centers in the border regions of the Russian Federation and the People's Republic of China, cooperation of our countries in the field of biopharmaceuticals and production of innovative pharmaceuticals and medical devices.

Today, Russia and China are ready to actively cooperate in the field of biotechnology. And synergies found in this cooperation suggest that it is the cross-border nature of cooperation, combining of all opportunities of our countries that will create great opportunities to make big difference to improve the health of our citizens.

“In the context of the pandemic, the role of healthcare has dramatically increased globally. Modern challenges require quick high-tech response in terms of creating and managing modern healthcare facilities and in the field of creating pharmaceuticals and medical devices. We hope to get a significant synergy in these areas through partnerships with Chinese manufacturers and investors," said Alexander Kulish.

“The Business Council supports the sharing of best practices in pharmacology. Today, China is a leading player in terms of technology advancements and Russia has many projects attractive to investors. Russia is ready to actively cooperate with the PRC. It is necessary not only to deal with exports and imports, but also share technologies between the two countries. Russian pharmaceutical companies are open for partnership, and the Russian-Chinese Business Council together with the Russian authorities are ready to promote the development of mutually beneficial bilateral relations between Chinese and Russian companies," said Evgeny Markin.